Showing results (1-10 of 334) with videos related to
Sort By:
Pageof 34
Cardiovascular Research|June 26, 2023
Non-alcoholic fatty liver disease: pathophysiological concepts and treatment optionsChristoph Grander, Felix Grabherr, Herbert TilgJournal of Clinical and Translational Hepatology|January 1, 2024
Nonalcoholic Fatty Liver Disease and the Intestinal Microbiome: An Inseparable LinkMaria Effenberger, Christoph Grander, Felix Grabherr, et al.Visceral Medicine|December 7, 2016
Non-Alcoholic Fatty Liver Disease: Cause or Effect of Metabolic SyndromeChristoph Grander, Felix Grabherr, Alexander R Moschen, et al.International Journal of Molecular Sciences|August 1, 2017
Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple InteractionsTimon E Adolph, Christoph Grander, Felix Grabherr, et al.Trends in Immunology|May 31, 2018
Liver-Microbiome Axis in Health and DiseaseTimon E Adolph, Christoph Grander, Alexander R Moschen, et al.Therapeutic Advances in Endocrinology and Metabolism|November 28, 2022
MAFLD: what 2 years of the redefinition of fatty liver disease has taught usFelix Grabherr, Christoph Grander, Maria Effenberger, et al.Expert Review of Clinical Immunology|December 27, 2023
The pathophysiology of MASLD: an immunometabolic perspectiveJulian Schwärzler, Felix Grabherr, Christoph Grander, et al.Frontiers in Endocrinology|September 27, 2019
Gut Dysfunction and Non-alcoholic Fatty Liver DiseaseFelix Grabherr, Christoph Grander, Maria Effenberger, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 13, 2023
Apelin and the gut microbiome: Potential interaction in human MASLDMaria Effenberger, Christoph Grander, Bela Hausmann, et al.Gut Microbes|December 31, 2020
The role of gut vascular barrier in experimental alcoholic liver disease and A. muciniphila supplementationChristoph Grander, Felix Grabherr, Ilaria Spadoni, et al.Pageof 34